Detrimental role of granulocyte-colony stimulating factor in neuromyelitis optica: Clinical case and histological evidence

Multiple Sclerosis Journal

Volumn 18, Issue 12, 2012, Pages 1801-1803

  Jacob, Anu ^a   Saadoun, Samira ^b   Kitley, Joanna ^c   Leite, Maria ^c   Palace, Jacqueline ^c   Schon, Frederick ^d   Papadopoulos, Marios C ^b  

^a WALTON CENTRE FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^c JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^d ST GEORGE S HOSPITAL   (United Kingdom)

Author keywords

aquaporin 4; Devic's syndrome; eosinophils; G CSF; neutrophils

Indexed keywords

AZATHIOPRINE; GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN; METHYLPREDNISOLONE; PREDNISOLONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ACUTE DISSEMINATED ENCEPHALOMYELITIS; ADULT; ARTICLE; CASE REPORT; CELL INFILTRATION; CLINICAL FEATURE; DISEASE EXACERBATION; GASTROENTERITIS; GRANULOCYTE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MULTIPLE SCLEROSIS; MYELOOPTIC NEUROPATHY; NERVE CELL; NEUTROPHIL COUNT; PATHOGENESIS; PLASMAPHERESIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SPINAL CORD; UPREGULATION; WHITE MATTER;

EID: 84861133404     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458512443994     Document Type: Article

References (11)

1. Lucchinetti CF, Mandler RN, McGavern D, et al. A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. Brain. 2002 ; 125: 1450-1461
2. Roemer SF, Parisi JE, Lennon VA, et al. Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis. Brain. 2007 ; 130: 1194-1205
3. Saadoun S, Waters P, Bell BA, et al. Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice. Brain. 2010 ; 133: 349-361
4. Jarius S, Paul F, Franciotta D, et al. Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: Results from 211 lumbar punctures. J Neurol Sci. 2011 ; 306: 82-90
5. Matsushita T, Tateishi T, Yonekawa T, et al. Increased CSF IL-17A, IL-6, CXCL8 and CXCL10 in patients with neuromyelitis optica at relapse and their clinical relevance. 5th joint triennial congress of the European and Americas Committees for Treatment and Research in Multiple Sclerosis ; 2011 Amsterdam, The Netherlands ; 2011..
6. Herges K, de Jong BA, Kolkowitz I, et al. Protective effect of an elastase inhibitor in a neuromyelitis optica-like disease driven by a peptide of myelin oligodendroglial glycoprotein. Mult Scler. 2012 ;:
7. Saadoun S, MacDonald C, Waters P, et al. Neutrophil protease inhibition reduces NMO-IgG-induced damage in mouse brain. Ann Neurol. 2012 ;:
8. Zhang H, Bennett JL, Verkman AS. Ex vivo spinal cord slice model of neuromyelitis optica reveals novel immunopathogenic mechanisms. Ann Neurol. 2012 ;:
9. Euler HH, Harten P, Zeuner RA, et al. Recombinant human granulocyte colony stimulating factor in patients with systemic lupus erythematosus associated neutropenia and refractory infections. J Rheumatol. 1997 ; 24: 2153-2157
10. Hasselblatt M, Jeibmann A, Riesmeier B, et al. Granulocyte- colony stimulating factor (G-CSF) and G-CSF receptor expression in human ischemic stroke. Acta Neuropathol. 2007 ; 113: 45-51
11. Openshaw H, Stuve O, Antel JP, et al. Multiple sclerosis flares associated with recombinant granulocyte colony-stimulating factor. Neurology. 2000 ; 54: 2147-2150